In vitro and in vivo data have indicated that IL-1β in particular promotes the migration and invasion of lung cancer cells, triggering more aggressive cancer phenotypes (Gelfo et al., 2020; Zhang et al., 2020) (Voronov et al., 2003; Das et al., 2020). Here, IL1B is linked to lung cancer.